Publish Ahead of Print

Original Article

Malignant pleural mesothelioma nodules remodel their surroundings to vascularize and grow
Ildiko Kovacs, Edina Bugyik, Katalin Dezso, Julia Tarnoki-Zach, Elod Mehes, Marton Gulyas, Andras Czirok, Elisabeth Lang, Michael Grusch, Karin Schelch, Balazs Hegedus, Ildiko Horvath, Nandor Barany, Zsolt Megyesfalvi, Anna Tisza, Zoltan Lohinai, Mir Alireza Hoda, Konrad Hoetzenecker, Francesco Pezzella, Sandor Paku, Viktoria Laszlo, Balazs Dome
Phase II study of nanoparticle albumin-bound paclitaxel monotherapy for relapsed non-small cell lung cancer with patient- reported outcomes (NLCTG1302)
Satoshi Shoji, Satoru Miura, Satoshi Watanabe, Aya Ohtsubo, Koichiro Nozaki, Yu Saida, Kosuke Ichikawa, Rie Kondo, Tomohiro Tanaka, Kenichi Koyama, Hiroshi Tanaka, Masaaki Okajima, Tetsuya Abe, Takeshi Ota, Takashi Ishida, Masato Makino, Akira Iwashima, Kazuhiro Sato, Naoya Matsumoto, Hirohisa Yoshizawa, Toshiaki Kikuchi
Totality outcome of afatinib sequential treatment in patients with EGFR mutation-positive non-small-cell lung cancer in South Korea (TOAST): Korean Cancer Study Group (KCSG) LU-19-22
Hyun Ae Jung, Min Hee Hong, Hyun Woo Lee, Kyung Hee Lee, Il Hwan Kim, Young Joo Min, Hee Kyung Ahn, Byoung Yong Shim, Yoon Hee Choi, Yun-Gyoo Lee, Jeong A Kim, Joung Soon Jang, Seong-Hoon Shin, Keon Uk Park, Jin Hyoung Kang, Keunchil Park
Efficacy and safety of camrelizumab plus apatinib in previously treated patients with advanced non-small cell lung cancer harboring EGFR or ALK genetic aberration
Guanghui Gao, Jian Ni, Yina Wang, Shengxiang Ren, Zhihua Liu, Gongyan Chen, Kangsheng Gu, Aimin Zang, Jun Zhao, Renhua Guo, Jianxing He, Xiaoyan Lin, Yueyin Pan, Zhiyong Ma, Zhehai Wang, Min Fan, Yunpeng Liu, Shundong Cang, Xinfeng Yang, Weixia Li, Quanren Wang, Caicun Zhou

Case Report


Study Protocol

Prospective evaluation of immunological, molecular-genetic, image-based and microbial analyses to characterize tumor response and control in patients with unresectable stage III NSCLC treated with concurrent chemoradiotherapy followed by consolidation therapy with durvalumab (PRECISION): protocol for a prospective longitudinal biomarker study
Lukas Käsmann, Julian Taugner, Chukwuka Eze, Alexander Nieto, Carolyn Pelikan, Benedikt Flörsch, Saskia Kenndoff, Thomas P. Hofer, Elfriede Nössner, Christian Schulz, Marcus Unterrainer, Amanda Tufman, Frederick Klauschen, Andreas Jung, Jens Neumann, Jörg Kumbrink, Niels Reinmuth, Peter Bartenstein, Claus Belka, Farkhad Manapov

iMDT Corner